Related Experiment Video
Updated: Feb 5, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
MiRNA-708/CUL4B axis contributes into cell proliferation and apoptosis of osteosarcoma
1Department of Orthopedic Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian, China. zhouhuan8103@126.com.
Objective:
The functions of miRNA-708 for various diseases have been confirmed. However, its roles in osteosarcoma are unclear. In this study, we aimed to explore the role of miRNA-708 in osteosarcoma.
Patients And Methods:
Detection of the expression of miRNA-708 and CUL4B was used by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Cells were transfected with miRNA-708 mimics (mimics group) and miRNA negative control (NC group). Detection of cell growth curve at 24 h, 48 h, 72 h, and 96 h was made by cell counting kit-8 (CCK-8). Examination of the apoptosis rate was made by flow cytometry. The identification of the regulatory function was made by the luciferase reporter assay. The expression level of CUL4B was detected by Western blot.
Results:
MiRNA-708 expression was reduced in the tumor cell lines. Compared with NC group, miRNA-708 expression was up-regulated by transfecting with mimics. Lower proliferation efficiency and higher cell apoptosis were showed in miRNA-708 mimics group relative to NC group. MiRNA-708 could regulate the expression of CUL4B by binding to its 3'UTR area. Furthermore, lower miRNA-708 and higher CUL4B were expressed in tumor tissues. MiRNA-708 expression was lower in tissues with IIB-III stage than that in IA-IIA stage.
Conclusions:
MiRNA-708/CUL4B axis contributes into cell proliferation and apoptosis of osteosarcoma.
Insights
MicroRNA-708 (miRNA-708) suppresses osteosarcoma growth by inhibiting CUL4B expression. This study reveals miRNA-708 as a potential therapeutic target for osteosarcoma, impacting cell proliferation and apoptosis.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- MicroRNA-708 (miRNA-708) has established roles in various diseases.
- Its specific functions in osteosarcoma remain largely uncharacterized.
- Understanding miRNA-708's role is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the role and mechanism of miRNA-708 in osteosarcoma.
- To determine the relationship between miRNA-708 and its potential target, CUL4B.
- To assess the impact of miRNA-708 on osteosarcoma cell behavior.
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) for miRNA-708 and CUL4B expression.
- Cell transfection with miRNA-708 mimics and negative control.
- Cell Counting Kit-8 (CCK-8) assay for cell proliferation.
- Flow cytometry for apoptosis analysis.
- Luciferase reporter assay for regulatory function confirmation.
- Western blot for CUL4B protein expression.
Main Results:
- MiRNA-708 expression was significantly reduced in osteosarcoma cell lines and tissues.
- Overexpression of miRNA-708 via mimics decreased cell proliferation and increased apoptosis.
- MiRNA-708 directly targets and downregulates CUL4B expression by binding to its 3' untranslated region (3'UTR).
- Tumor tissues exhibited lower miRNA-708 and higher CUL4B expression, correlating with advanced stages (IIB-III).
Conclusions:
- The miRNA-708/CUL4B axis plays a critical role in regulating osteosarcoma cell proliferation and apoptosis.
- MiRNA-708 acts as a tumor suppressor in osteosarcoma by targeting CUL4B.
- This axis represents a potential therapeutic target for osteosarcoma treatment.
Related Concept Videos
Apoptosis
Cells Coordinate Growth and Proliferation
Hypothalamic-Pituitary Axis
Binet's Contribution to Measures of Intelligence
Abnormal Proliferation
Perpendicular-Axis Theorem
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...

